GlassScriptPhysician profile
Abralena Wilson
NPI 1659406593
$9,704.71
in general payments reported to CMS, 2019-2025
27 companies · $787 in 2025
The $787 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $553 · 2021: $229 · 2022: $868 · 2023: $5,749 · 2024: $583 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,203 · Travel and Lodging: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,202.92 |
| Travel and Lodging | $916.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,769.43 | 2021-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Davol INC. | $1,497.85 | 2020-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $999.02 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Allergan, INC. | $649.65 | 2019 | |
| Medline Industries LP | $372.44 | 2019-2020 | |
| Smith+Nephew, INC. | $163.79 | 2024 | Collagenase Santyl, Versajet, Regranex |
| Acell, INC. | $142.04 | 2020 | |
| Organogenesis INC. | $135.62 | 2024 | Apligraf |
| Tactile Systems Technology INC | $132.94 | 2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $129.89 | 2022-2023 | Keytruda |
| Grifols USA, LLC | $120.43 | 2024 | Thrombate III |
| Triad Life Sciences INC. | $100.00 | 2022 | |
| Chiesi USA, INC. | $72.75 | 2021-2023 | Cleviprex |
| Innocoll Pharmaceuticals Limited | $68.03 | 2022 | |
| Zimvie INC. | $55.20 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $44.91 | 2022-2024 | Deknatel |
| Hologic Sales and Service, LLC | $30.67 | 2024 | Trident Specimen Radiography System, Localizer |
| Janssen Biotech, INC. | $28.16 | 2025 | Tecvayli, Darzalex |
| Aroa Biosurgery Incorporated | $26.84 | 2025 | |
| Stemline Therapeutics INC. | $24.82 | 2024 | Orserdu |
| Janssen Pharmaceuticals, INC | $24.49 | 2023 | Xarelto |
| Misonix INC | $23.52 | 2021 | |
| Masimo Corporation | $20.80 | 2023 | Patient Safetynet System |
| Tela Bio, INC. | $20.63 | 2024 | Ovitex 2s |
| Heron Therapeutics, INC. | $20.32 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.53 | 2021 | |
| Boston Scientific Corporation | $13.94 | 2024 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abralena Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.